Therapeutic targets in malignant glioblastoma microenvironment

Area of Science:

• Oncology
• Cancer Biology
• Radiotherapy Research

Background:

• The tumor microenvironment plays a critical role in cancer suppression and progression.
• Disruption of the microenvironment by tumor cells promotes cancer growth, invasion, and recruitment of supportive nonmalignant cells.
• Normal tissue responses to cancer are consistent, suggesting indirect therapeutic control via the microenvironment is feasible.

Purpose of the Study:

• To explore the glioblastoma (GBM) microenvironment as a source of therapeutic targets.
• To examine the interplay between radiotherapy (RT) and the GBM microenvironment.
• To propose strategies for targeting RT-induced microenvironmental changes for improved GBM treatment.

Main Methods:

• Review and discussion of existing evidence on the GBM microenvironment.
• Analysis of how radiotherapy affects tumor and tissue microenvironments.
• Conceptualization of therapeutic approaches targeting the microenvironment in conjunction with RT.

Main Results:

• Viable therapeutic targets exist within the complex GBM microenvironment (vasculature, inflammatory/immune cells, growth factors, extracellular matrix).
• Radiotherapy significantly alters the microenvironment of both normal tissues and GBM tumors.
• Targeting RT-induced microenvironmental modifications presents a promising avenue for enhancing therapeutic outcomes.

Conclusions:

• The GBM microenvironment offers multiple targets for cancer therapy.
• Radiotherapy's impact on the microenvironment can be leveraged for treatment optimization.
• Combined approaches targeting the microenvironment and utilizing RT hold potential for improved glioblastoma management.